Plausibility of therapeutic effects of Rho kinase inhibitors against Severe Acute Respiratory Syndrome Coronavirus 2 (COVID-19)

Página do item simplificado
dc.creatorAbedi, Farshad
dc.creatorRezaee, Ramin
dc.creatorKarimi, Gholamreza
dc.date.accessioned2020-05-25T20:40:46Z
dc.date.available2020-05-25T20:40:46Z
dc.date.issued2020-06
dc.description.abstractIndisponível.pt_BR
dc.identifier.citationABEDI, F.; REZAEE, R.; KARIMI, G. Plausibility of therapeutic effects of Rho kinase inhibitors against Severe Acute Respiratory Syndrome Coronavirus 2 (COVID-19). Pharmacological Research, [S.l.], v. 156, June 2020.pt_BR
dc.identifier.urihttps://repositorio.ufla.br/handle/1/41215
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S1043661820311166pt_BR
dc.languageen_USpt_BR
dc.publisherElsevierpt_BR
dc.rightsopenAccesspt_BR
dc.sourcePharmacological Researchpt_BR
dc.subjectSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)pt_BR
dc.subjectCOVID-19pt_BR
dc.subjectRho kinase inhibitorspt_BR
dc.titlePlausibility of therapeutic effects of Rho kinase inhibitors against Severe Acute Respiratory Syndrome Coronavirus 2 (COVID-19)pt_BR
dc.typeArtigopt_BR

Arquivos

Licença do pacote

Agora exibindo 1 - 1 de 1
Imagem de Miniatura
Nome:
license.txt
Tamanho:
953 B
Formato:
Item-specific license agreed upon to submission
Descrição:
Baixar

Coleções

FCS - Artigos sobre Coronavirus Disease 2019 (COVID-19)